Related Experiment Video
Updated: Mar 18, 2026
08:53
Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices
Published on: October 3, 2016
19.1K
The NIH Countermeasures Against Chemical Threats Program: overview and special challenges
1National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.
Annals of the New York Academy of Sciences
|July 12, 2016
Summary
Developing medical countermeasures is crucial for chemical emergencies, addressing rapid-acting therapies for toxic exposures and their long-term effects. The NIH CounterACT Program funds vital research to improve preparedness and response.
Area of Science:
- Toxicology
- Emergency Medicine
- Pharmacology
Background:
- Chemical emergencies, from terrorist attacks to industrial accidents, pose significant threats.
- Rapid and lethal chemical agents necessitate swift medical interventions.
- Diverse populations and potential long-term health effects complicate emergency response.
Framework:
- The National Institutes of Health (NIH) Countermeasures Against Chemical Threats (CounterACT) Program is a key initiative.
- This program supports research for developing therapeutics against chemical exposures.
- It involves grants, contract resource facilities, and interagency collaborations.
Implementation:
- The NIH CounterACT Program funds a network of investigators.
- Research spans various therapeutic strategies to mitigate chemical toxicity.
- Interagency agreements with Department of Defense laboratories enhance capabilities.
Implications:
- Effective medical countermeasures are vital for public health preparedness.
- Advancements in therapeutics can reduce mortality and morbidity from chemical events.
- The program fosters high-quality research to address critical threats.
